EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain Injury

Yunfan Yang, Zixiang Li, Xiaochong Fan, Chao Jiang, Junmin Wang, Yousef Rastegar-Kashkooli, Tom J Wang, Junyang Wang, Menglu Wang, Nannan Cheng, Xiqian Yuan, Xuemei Chen and 2 more

ACS Nano · 2024-07-02 · 18 (26) · 16450-16467

DOI: 10.1021/acsnano.4c03425 ↗

At a glance

Übersichtsarbeit in ACS Nano, published online on 2024-06-19. Written by Yunfan Yang and 13 co-authors. Institution: Department of Pain Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan, P. R. China. Major MEDLINE topics: Reactive Oxygen Species, Ischemic Stroke, Brain Injuries, Traumatic, Inflammation. Cited 128 times so far (Crossref); 118 references. Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Nanozymes, which can selectively scavenge reactive oxygen species (ROS), have recently emerged as promising candidates for treating ischemic stroke and traumatic brain injury (TBI) in preclinical models. ROS overproduction during the early phase of these diseases leads to oxidative brain damage, which has been a major cause of mortality worldwide. However, the clinical application of ROS-scavenging enzymes is limited by their short in vivo half-life and inability to cross the blood-brain barrier. Nanozymes, which mimic the catalytic function of natural enzymes, have several advantages, including cost-effectiveness, high stability, and easy storage. These advantages render them superior to natural enzymes for disease diagnosis and therapeutic interventions. This review highlights recent advancements in nanozyme applications for ischemic stroke and TBI, emphasizing their potential to mitigate the detrimental effect of ROS overproduction, oxidative brain damage, inflammation, and blood-brain barrier compromise. Therefore, nanozymes represent a promising treatment modality for ROS overproduction conditions in future medical practices.

Subjects

MeSH terms (MEDLINE)

Reactive Oxygen SpeciesIschemic StrokeBrain Injuries, TraumaticInflammationHumansAnimalsBlood-Brain BarrierNanostructures

Author keywords

Blood-brain barrierIschemic StrokeNanozymesNeuroinflammationOxidative Brain DamageReactive Oxygen SpeciesTherapeutic interventionsTraumatic Brain Injury

Substances

Reactive Oxygen Species

Authors and institutions

  • Department of Pain Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan, P. R. China.
  • Department of Human Anatomy, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan, P. R. China.
  • Department of Neurology, People's Hospital of Zhengzhou University, Zhengzhou 450000, Henan, P. R. China.
  • School of International Education, Zhengzhou University, Zhengzhou 450001, Henan, P. R. China.
  • Program in Behavioral Biology, The Johns Hopkins University, Baltimore, Maryland 21218, United States.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan, P. R. China.

ORCID profiles: Bing Jiang, Jian Wang

Funding

  • National Natural Science Foundation of China

Cite

APA

Yang, Y., Li, Z., Fan, X., Jiang, C., Wang, J., Rastegar-Kashkooli, Y., Wang, T. J., Wang, J., Wang, M., Cheng, N., Yuan, X., Chen, X., Jiang, B., & Wang, J. (2024). Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain Injury. ACS Nano, 18(26), 16450-16467. https://doi.org/10.1021/acsnano.4c03425

Vancouver

Yang Y, Li Z, Fan X, Jiang C, Wang J, Rastegar-Kashkooli Y, et al. Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain Injury. ACS Nano. 2024;18(26):16450-16467. doi:10.1021/acsnano.4c03425

BibTeX
@article{Yang2024,
  author = {Yang, Yunfan and Li, Zixiang and Fan, Xiaochong and Jiang, Chao and Wang, Junmin and Rastegar-Kashkooli, Yousef and Wang, Tom J and Wang, Junyang and Wang, Menglu and Cheng, Nannan and Yuan, Xiqian and Chen, Xuemei and Jiang, Bing and Wang, Jian},
  title = {Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain Injury},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {26},
  pages = {16450--16467},
  doi = {10.1021/acsnano.4c03425}
}
Start for free →